Marijuana MSO PharmaCann raises $39.5 million through upsized debt offering

Women, minority execs show few gains in U.S. cannabis industry, according to the latest data from the MJBiz Diversity, Inclusion and Equity Report. Get your copy here.


Privately held marijuana multistate operator PharmaCann raised net proceeds of $39.5 million through an upsized offering of senior secured notes.

The funding “will be used for strategic growth opportunities and general corporate purposes,” according to a Thursday news release.

The upsized debt offering follows an $85 million notes issuance announced last June, which brought PharmaCann net proceeds of nearly $80 million.

That offering of 12% senior secured notes involved unspecified “leading U.S. and Canadian lenders.”

The notes are due in June 2025.

PharmaCann said it now has $125 million worth of notes outstanding.

Business leaders need reliable industry data and in-depth analysis to make smart investments and informed decisions in these uncertain economic times.

Order your 2022 MJBiz Factbook, out now!

Featured Inside:
  • 200+ pages and 50 charts with key data points
  • State-by-state guide to regulations, taxes & opportunities
  • Segmented research reports for the marijuana + hemp industries
  • Accurate financial forecasts + investment trends

 

Stay ahead of the curve and avoid costly missteps in the rapidly evolving cannabis industry.

The Chicago-based company operates in Illinois, Maryland, Massachusetts, New York, Ohio and Pennsylvania.

In October, PharmaCann announced a deal to acquire Colorado-based cannabis company LivWell Enlightened Health, which also operates in Michigan.

Reuters reported last August that PharmaCann was planning to go public in the fall, but a public stock offering has not materialized.